Skeletal Maturation and Endocrine Health in Young Adults
Launched by HOLBAEK SYGEHUS · Jul 15, 2024
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Population-based, nationwide, cross-sectional, clinical study with already available early life exposure data including bio banked neonatal biological samples. An embedded design using the full 2006+2007 birth cohorts is used to demonstrate external validity of the clinically assessed cohort. We will obtain the necessary ethics and regulatory approval and individual consent from the participants who are all aged 18.
The overall aim of the project addresses whether the following sets of potential determinants are associated with young adult hormonal status, lipids, bone turnover markers, bo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals (n = 2000) born in Denmark in 2006 or 2007
- • Are 18 years old and alive at the time of the clinical examination
- Exclusion Criteria:
- • Pregnancy or lactation
- • No DBS samples available
- • Lack of consent to use DBS samples or national health registries
- • Emigration or disappearance
About Holbaek Sygehus
Holbæk Sygehus, a leading healthcare institution in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on collaboration and ethical practice, the hospital provides a robust infrastructure for conducting a diverse range of studies across various therapeutic areas. Holbæk Sygehus is committed to fostering a patient-centered approach, ensuring that clinical trials not only contribute to scientific knowledge but also prioritize safety and well-being. Through its experienced research team and state-of-the-art facilities, Holbæk Sygehus plays a pivotal role in the development of new therapies and enhancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, , Denmark
Aarhus, , Denmark
Copenhagen, , Denmark
Frederiksberg, , Denmark
Holbæk, , Denmark
Hvidovre, , Denmark
Køge, , Denmark
Odense, , Denmark
Odense, , Denmark
Patients applied
Trial Officials
Bo Abrahamsen, MD, PhD
Study Chair
OPEN, University of Southern Denmark, Odense and Department of Medicine 1, Holbæk Hospital, Holbæk
Katrine H Rubin, MHS, PhD
Principal Investigator
OPEN, Department of Clinical Research, University of Southern Denmark and Odense University Hospital
Bente Langdahl, MD, PhD
Principal Investigator
Department of Clinical Medicine and Department of Endocrinology and Diabetes, Aarhus University
Peter Vestergaard, MD, PhD
Principal Investigator
Faculty of Medicine, Aalborg University and Department of Endocrinology, Aalborg University Hospital
Berit L Heitmann, DMD, PhD
Principal Investigator
The Parker Institute, Frederiksberg Hospital, Frederiksberg
Mina N Händel, Msc, PhD
Principal Investigator
The Parker Institute, Frederiksberg Hospital, Frederiksberg
Charlotte L Tofteng, MD, PhD
Principal Investigator
Department of CIinical Medicine, Endocrinology, Zealand University Hospital, Køge
Pernille Bach-Mortensen, MD, PhD
Principal Investigator
Department of Endocrinology, Amager and Hvidovre Hospital, Hvidovre
Pernille Hermann, MD, PhD
Principal Investigator
Department of Endocrinology, Odense University Hospital, Odense
Niklas R Jørgensen, MD, PhD
Principal Investigator
Department of Clinical Biochemistry and Centre of Diagnostic Investigation,Rigshospitalet Copenhagen
Jonas Bybjerg-Grauholm, MSE
Principal Investigator
Danish Center for Neonatal Screening, Statens Serum Institut, Copenhagen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported